ADC Therapeutics Announces New Employee Inducement Grant
ADC Therapeutics granted a new employee inducement options to purchase 17,000 common shares on November 2, 2026, disclosed under NYSE Rule 303A.08. The grant was approved by the Compensation Committee under the company's Inducement Plan and vests over four years, subject to continued employment.
Key figures
- Options granted
- 17000
- Vesting schedule
- 25% at first anniversary, then 1/48th monthly, fully vested at fourth anniversary
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.